NanoViricides
NNVC | AMEX
$1.24
+$0.01 (+0.81%)
At close: Nov 16, 2026, 4:00 PM ET
$1.23
-$0.01 (-0.81%)
After-hours:
Nov 16, 2026, 5:09 PM ET
+0.81%
(1D)Rating
26.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #882/1021 (Top 86%)
Key Statistics
Market Data
Market Cap $31.65M
1D Range
1.23 1.27
52W Range
0.85 1.86
Valuation (TTM)
PE -3.02
PB 0.00
EV/EBITDA -0.00
Valuation (NTM)
Forward PE N/A
Forward PEG -0.28
Price Target $0.00
Cash Flow
FCF Yield 10109478.4%
SBC Adj. FCF Yield 10109872.2%
SBC Impact 0.0%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 25.6% |
10.7%
FCF 3Y | 5Y 150.0% |
100.0%
Returns
ROA -83.2%
ROE -91.1%
ROIC -95.7%
Financial Health
Net Cash
$2.79T
Current Ratio 2.66
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company'...
Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Oct 26, 2005
Website www.nanoviricides.com
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove NNVC